For instance, SC4 has a unique pathway called “Signaling by FGFR3 point mutants in cancer” that has been previously associated with urothelial, breast, endometrial, squamous lung cancers, and ovarian cancer [62]. This evidence concerns the gene FGFR3 and ovarian carcinoma.